DS-007

N/A

Report date: 2025/01/26 17:59:38

Base Information

Drug NameDS-007
Drug Alias NameGD2 mAb (DartsBio Pharmaceuticals)Ganglioside GD2 Monoclonal Antibody (DartsBio Pharmaceuticals)Anti-GD2 Monoclonal Antibody (DartsBio Pharmaceuticals)DS-007
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionDisialoganglioside GD2 inhibitors
TargetsDisialoganglioside GD2
Therapy Area/IndicationsSmall Cell Lung CarcinomaNeuroblastomaOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDartsbio Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDartsbio Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaNeuroblastomaOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A